A detailed history of Nisa Investment Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 7,069 shares of AMRX stock, worth $55,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,069
Previous 228,917 96.91%
Holding current value
$55,491
Previous $1.45 Million 96.01%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$6.42 - $8.83 $1.42 Million - $1.96 Million
-221,848 Reduced 96.91%
7,069 $58,000
Q2 2024

Jul 19, 2024

BUY
$5.36 - $7.11 $1.19 Million - $1.58 Million
222,144 Added 3279.85%
228,917 $1.45 Million
Q1 2024

May 01, 2024

BUY
$5.24 - $6.34 $382 - $462
73 Added 1.09%
6,773 $41,000
Q2 2023

Aug 11, 2023

BUY
$1.33 - $3.1 $6,889 - $16,058
5,180 Added 340.79%
6,700 $20,000
Q1 2022

Apr 29, 2022

SELL
$3.9 - $4.89 $2,457 - $3,080
-630 Reduced 29.3%
1,520 $6,000
Q2 2021

Aug 06, 2021

SELL
$5.12 - $6.82 $91,648 - $122,078
-17,900 Reduced 89.28%
2,150 $11,000
Q4 2020

Jan 25, 2021

BUY
$3.95 - $5.42 $4,542 - $6,233
1,150 Added 6.08%
20,050 $92,000
Q2 2020

Jul 27, 2020

SELL
$2.87 - $5.46 $33,866 - $64,428
-11,800 Reduced 38.44%
18,900 $90,000
Q1 2020

Apr 17, 2020

BUY
$2.46 - $5.35 $74,722 - $162,506
30,375 Added 9346.15%
30,700 $107,000
Q4 2019

Jan 17, 2020

SELL
$2.65 - $5.56 $103,668 - $217,507
-39,120 Reduced 99.18%
325 $2,000
Q3 2019

Oct 17, 2019

BUY
$2.29 - $7.1 $89,584 - $277,752
39,120 Added 12036.92%
39,445 $114,000
Q1 2019

Apr 17, 2019

SELL
$11.87 - $14.84 $182,584 - $228,268
-15,382 Reduced 97.93%
325 $5,000
Q3 2018

Oct 16, 2018

BUY
$16.4 - $24.27 $252,264 - $373,321
15,382 Added 4732.92%
15,707 $349,000
Q2 2018

Jul 19, 2018

BUY
$13.95 - $20.2 $4,533 - $6,565
325 New
325 $5,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.